Ardelyx, Inc. (ARDX)
3.34
-0.04
(-1.18%)
USD |
NASDAQ |
Oct 02, 16:00
3.335
0.00 (0.00%)
After-Hours: 20:00
Ardelyx Price : 3.34 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 3.38 | 3.40 | 3.29 | 3.34 | 4.092M |
| Oct 01, 2026 | 3.46 | 3.46 | 3.355 | 3.38 | 4.107M |
| Sep 30, 2026 | 3.43 | 3.46 | 3.365 | 3.42 | 4.413M |
| Sep 29, 2026 | 3.42 | 3.435 | 3.31 | 3.39 | 4.434M |
| Sep 28, 2026 | 3.40 | 3.44 | 3.375 | 3.41 | 3.318M |
| Sep 25, 2026 | 3.47 | 3.485 | 3.40 | 3.42 | 2.126M |
| Sep 24, 2026 | 3.47 | 3.49 | 3.415 | 3.45 | 3.234M |
| Sep 23, 2026 | 3.60 | 3.62 | 3.42 | 3.48 | 6.280M |
| Sep 22, 2026 | 3.54 | 3.63 | 3.47 | 3.62 | 3.989M |
| Sep 21, 2026 | 3.455 | 3.525 | 3.37 | 3.50 | 2.834M |
| Sep 18, 2026 | 3.38 | 3.445 | 3.33 | 3.42 | 6.443M |
| Sep 17, 2026 | 3.44 | 3.495 | 3.34 | 3.38 | 4.232M |
| Sep 16, 2026 | 3.40 | 3.43 | 3.34 | 3.39 | 5.378M |
| Sep 15, 2026 | 3.52 | 3.521 | 3.38 | 3.40 | 5.096M |
| Sep 14, 2026 | 3.60 | 3.60 | 3.51 | 3.52 | 4.364M |
| Sep 11, 2026 | 3.65 | 3.68 | 3.56 | 3.58 | 5.690M |
| Sep 10, 2026 | 3.77 | 3.78 | 3.61 | 3.62 | 4.047M |
| Sep 09, 2026 | 3.73 | 3.915 | 3.69 | 3.80 | 4.474M |
| Sep 08, 2026 | 3.76 | 3.80 | 3.71 | 3.77 | 2.959M |
| Sep 04, 2026 | 3.68 | 3.78 | 3.68 | 3.78 | 2.982M |
| Sep 03, 2026 | 3.80 | 3.83 | 3.685 | 3.71 | 3.470M |
| Sep 02, 2026 | 3.75 | 3.835 | 3.725 | 3.80 | 3.914M |
| Sep 01, 2026 | 3.78 | 3.815 | 3.75 | 3.76 | 3.647M |
| Aug 31, 2026 | 3.80 | 3.81 | 3.68 | 3.78 | 3.802M |
| Aug 28, 2026 | 3.81 | 3.90 | 3.75 | 3.81 | 5.134M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Capricor Therapeutics, Inc. | 8.95 |
| REGENXBIO, Inc. | 7.43 |
| Compass Therapeutics, Inc. | 0.8567 |
| ARS Pharmaceuticals, Inc. | 4.07 |
| Sionna Therapeutics, Inc. | 4.91 |
Price Related Metrics
| PS Ratio | 1.814 |
| Price to Book Value | 5.584 |
| Earnings Yield | -6.77% |
| Market Cap | 832.15M |